Icotinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. By inhibiting EGFR signaling, it prevents the growth of cancer cells. It is taken orally and is often used as a targeted therapy in patients with specific mutations in the EGFR gene.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Icotinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Icotinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Icotinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
